(Prothioconazole) (CAS No. 178928-70–6) and (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 3808.92.15) 5.1% No change No change On or before 12/31/2020 . 840. Trifloxystrobin + prothioconazole formulations Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.09.51 Product mixtures containing methyl (E)-methoxyimino-{(E)-2-[1-(α,α,α-trifluoro-m-tolyl)ethylideneaminooxy]-o-tolyl}acetate (Trifloxystrobin) (CAS No. 141517–21–7) and 2-[(2RS)-2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2H-1,2,4-triazole-3(4H)-thione (Prothioconazole) (CAS No. 178928–70–6) (provided for in subheading 3808.92.15) 4.1% No change No change On or before 12/31/2020 . 841. Gaucho XT Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.09.52 Product mixtures containing 1-(6-chloro-3-pyridinyl)methyl-N-nitroimidazolidin-2-ylideneamine (Imidacloprid) (CAS No. 138261–41–3), methyl N-(2-methoxyacetyl)-N-(2,6-xylyl)-DL-alaninate (Metalaxyl) (CAS No. 57837–19–1) and (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3 -ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 3808.92.15) Free No change No change On or before 12/31/2020 . 842. Trifloxystrobin and Tebuconazole formulations Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new heading: 9902.09.53 Product mixtures containing methyl (E)-methoxyimino-{(E)-2-[1-(α,α,α-trifluoro-m-tolyl)ethylideneaminooxy]-o- tolyl}acetate (Trifloxystrobin) (CAS No. 141517–21–7) and (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3 -ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 3808.92.15) Free No change No change On or before 12/31/2020 . 843. Fluopyram and Pyrimethanil formulations Subchapter II of chapter 99 is amended by inserting in numerical sequence the following new